9 results
Summary of dosing recommendations in renal impairment of commonly used hypoglycaemic agents

#Diabetes #Diabetic #Medications #Pharmacology #Dosing
hypoglycaemic agents ... #Medications #Pharmacology ... Renal #Impairment #CKD ... #Table #GFR #Hypoglycemics
Intern Pocket Cards - Pharmacologic Pain Management Options
Anti-inflammatory:
 • Acetaminophen (24 hours: < 3-4g in healthy
Pocket Cards - Pharmacologic ... adults, <3g in CKD ... cirrhosis) • Oral NSAIDs ... ketorolac (avoid NSAIDs ... if CKD or >2 of
Adjusted Pain Medication Dosing based on GFR

#Renal #Dosing #Pain #Pharmacology #Opiates #CKD #Gabapentin #Table
Dosing based on GFR ... #Dosing #Pain #Pharmacology ... #Opiates #CKD # ... Gabapentin #Table
Nonopioid Analgesic Agents
Acetaminophen
Aspirin
NSAIDs
Amitriptyline
Duloxetine
Gabapentin
Pregabalin
Lidocaine Patch
Capsaicin Patch

#Nonopioid #Analgesic #medications #drugs #comparison #table #pharmacology
Nonopioid Analgesic Agents ... Acetaminophen Aspirin NSAIDs ... drugs #comparison #table ... #pharmacology
Effects of Prostaglandins and NSAIDs on the Kidney
Effects of Prostaglandins on the Kidney:
 • The vasodilatory
Prostaglandins and NSAIDs ... is increased in CKD ... use in CKD with ... Prostaglandins #NSAIDs ... renal #nephrology #pharmacology
Phosphate binders - quick reference chart of maximum daily dose. Most patients with CKD will require
patients with CKD ... phosphate binding agents ... since they are not able ... Purposes Only* #CKD ... #Dose #Dosing #Pharmacology
NSAID Dosing in CKD
 • Carboxylic Acids: Salsalate, Choline Mg trisalicylate
 • Acetic Acids: Indomethacin, Tolmetin,
NSAID Dosing in ... CKD • Carboxylic ... Celecoxib #NSAID ... #Dosing #CKD #pharmacology ... #table
Hyperkalemia - Diagnosis and Management - GrepMed Handbook

S/Sx: Most pts asymptomatic. Weakness, cramping, nausea, paresthesias, palpitations,
K+, ACEi/ARBs, NSAIDs ... esp w oliguria / GFR ... Labs: BMP (Assess GFR ... VBG (acidosis), CK ... Elimination (see Table
Causes of Secondary Hypertension - Workup and Differential Diagnosis
Approach (when evaluation should be done):
1. Severe or
antihypertensive agents ... with previously stable ... Pheochromocytoma • Toxic: NSAlDs ... parenchymal disease: CKD